-
-
-
-
-
-
-
BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS
-
-
-
-
-
-
-
Bausch Health completes DURECT acquisition for $63 million
-
-
-
-
-
-
-
Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences
-
-
-
-
-
-
-
Bausch + Lomb Corporation stock gains on reports of private equity interest
-
-
-
-
-
-
-
Bausch + Lomb Completes Acquisition of XIIDRA®
-
-
-
-
-
-
-
Bausch + Lomb Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of XIIDRA®
-
-
-
-
-
-
-
Nike, Constellation Brands fall premarket; Apple, Carnival rise
-
1,199,225 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


